Companies similar to NOVARTIS AG (NVS)
NOVARTIS AG (NVS)'s closest peers include Merck & Co. (MRK), Pfizer (PFE), Johnson & Johnson (JNJ), Bristol Myers Squibb (BMY), AbbVie (ABBV), Lilly (Eli) (LLY) and Biogen (BIIB). This peer set is drawn from NVS's enriched company profile and is informational only — not financial advice.
Similar companies
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$124.40 (as of 2026-07-20) · market cap $315.5B
-
PfizerPFEHealth Care
Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular,…
$24.75 (as of 2026-07-20) · market cap $141.6B
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$248.82 (as of 2026-07-20) · market cap $604.6B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.16 (as of 2026-07-20) · market cap $124.3B
-
AbbVieABBVHealth Care
Global biopharmaceutical company with leadership positions in immunology, neuroscience, oncology, and aesthetics targeting complex diseases.
$253.38 (as of 2026-07-20) · market cap $449.6B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,146.90 (as of 2026-07-20) · market cap $1.11T
-
BiogenBIIBHealth Care
Biogen is a global biotechnology company developing and commercializing therapies across neurology, immunology, and rare genetic disease.
$199.95 (as of 2026-07-20) · market cap $30.1B
Not quite? Describe exactly what you want →
Peers are drawn from NVS's enriched profile (the same similarity signal the chat uses for "companies like NVS"). See the full profile: NOVARTIS AG (NVS).
Last updated 2026-07-20.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.